Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Beta-ureidopropionase deficiency (deletion/duplication analysis on UPB1) CGC Genetics Unilabs Portugal | 1 | 1 |
|
CDON Gene Holoprosencephaly type 11 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
CDON - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Brain Malformations Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 247 | 161 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
qGenEx Intellectual disability Quantitative Genomic Medicine Laboratories, SL Spain | 3 | 1969 |
|
PreventionGenetics, part of Exact Sciences United States | 177 | 161 |
|
Invitae Microphthalmia, Anophthalmia, Coloboma (MAC) and Anterior Segment Dysgenesis Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 130 | 81 |
|
Genetic Services Laboratory University of Chicago United States | 2 | 16 |
|
Holoprosencephaly Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 8 | 8 |
|
Holoprosencephaly-11 via the CDON Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Holoprosencephaly, Autosomal Dominant, Nonsyndromic, Panel PreventionGenetics, part of Exact Sciences United States | 10 | 14 |
|
CGC Genetics Unilabs Portugal | 1 | 1307 |
|
Pituitary hormone deficiency (WES based NGS panel of 29 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 29 |
|
Holoprosencephaly 11 (sequence analysis of CDON gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 18 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.